Common drugs tested to reverse MS disability

NCT ID NCT05131828

Summary

This trial tested whether a combination of two existing, safe drugs—metformin (for diabetes) and clemastine (an antihistamine)—could help repair the protective coating around nerves in people with relapsing multiple sclerosis (MS). The goal was to see if this repair process, called remyelination, could protect nerves and potentially slow or reverse disability. The 70 participants, aged 25-50, took the drug combination or a placebo for 24 weeks while continuing their standard MS treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Addenbrooke's Hospital

    Cambridge, United Kingdom

Conditions

Explore the condition pages connected to this study.